These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 22643717)

  • 1. Ethics of the heart: ethical and policy challenges in the treatment of advanced heart failure.
    Fields AV; Kirkpatrick JN
    Perspect Biol Med; 2012; 55(1):71-80. PubMed ID: 22643717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethical dilemmas in device treatment for advanced heart failure.
    Kirkpatrick JN; Fedson SE; Verdino R
    Curr Opin Support Palliat Care; 2007 Dec; 1(4):267-73. PubMed ID: 18685373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethical challenges in advanced heart failure.
    Kini V; Kirkpatrick JN
    Curr Opin Support Palliat Care; 2013 Mar; 7(1):21-8. PubMed ID: 23328735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. REMATCH and beyond: the cost of treating heart failure using an implantable left ventricular assist device.
    Dembitsky WP
    Semin Cardiothorac Vasc Anesth; 2006 Sep; 10(3):253-5. PubMed ID: 16959761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implantable defibrillators and beta-blockers in patients with left ventricular dysfunction: economic, ethical, and legal considerations.
    Silver MT
    Am Heart J; 2007 Apr; 153(4 Suppl):59-64. PubMed ID: 17394904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The next treatment option: using ventricular assist devices for heart failure.
    Stahovich M; Chillcott S; Dembitsky WP
    Crit Care Nurs Q; 2007; 30(4):337-46. PubMed ID: 17873570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Critical appraisal of costly therapy modalities for heart failure in a developing country.
    Chemello D; Goldraich L; Alvarez J; Beck-da-Silva L; Clausell N
    Curr Heart Fail Rep; 2013 Dec; 10(4):421-6. PubMed ID: 24072512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous use of implantable cardioverter-defibrillators and left ventricular assist devices in patients with severe heart failure.
    Kühne M; Sakumura M; Reich SS; Sarrazin JF; Wells D; Chalfoun N; Crawford T; Boonyapisit W; Horwood L; Chugh A; Good E; Jongnarangsin K; Bogun F; Oral H; Morady F; Pagani F; Pelosi F
    Am J Cardiol; 2010 Feb; 105(3):378-82. PubMed ID: 20102952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Device therapy in the treatment of heart failure.
    Nichols N
    Can J Cardiovasc Nurs; 2006; 16(1):28-31. PubMed ID: 16615262
    [No Abstract]   [Full Text] [Related]  

  • 10. Economic implications and cost-effectiveness of implantable cardioverter defibrillator and cardiac resynchronization therapy.
    Bernard ML; Gold MR
    Heart Fail Clin; 2011 Apr; 7(2):241-50, ix. PubMed ID: 21439502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statement regarding the pre and post market assessment of durable, implantable ventricular assist devices in the United States: executive summary.
    Acker MA; Pagani FD; Stough WG; Mann DL; Jessup M; Kormos R; Slaughter MS; Baldwin T; Stevenson L; Aaronson KD; Miller L; Naftel D; Yancy C; Rogers J; Teuteberg J; Starling RC; Griffith B; Boyce S; Westaby S; Blume E; Wearden P; Higgins R; Mack M
    Ann Thorac Surg; 2012 Dec; 94(6):e163-8. PubMed ID: 23153480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statement regarding the pre and post market assessment of durable, implantable ventricular assist devices in the United States.
    Acker MA; Pagani FD; Stough WG; Mann DL; Jessup M; Kormos R; Slaughter MS; Baldwin T; Stevenson L; Aaronson KD; Miller L; Naftel D; Yancy C; Rogers J; Teuteberg J; Starling RC; Griffith B; Boyce S; Westaby S; Blume E; Wearden P; Higgins R; Mack M
    Ann Thorac Surg; 2012 Dec; 94(6):2147-58. PubMed ID: 23153481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The technological imperative and the battle for the hearts of America.
    Gillick MR
    Perspect Biol Med; 2007; 50(2):276-94. PubMed ID: 17468543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The need for a low-cost ventricular assist device in India.
    Bhide RK
    Artif Organs; 2010 Sep; 34(9):792. PubMed ID: 20636445
    [No Abstract]   [Full Text] [Related]  

  • 15. Cost-effectiveness analysis of continuous-flow left ventricular assist devices as destination therapy.
    Rogers JG; Bostic RR; Tong KB; Adamson R; Russo M; Slaughter MS
    Circ Heart Fail; 2012 Jan; 5(1):10-6. PubMed ID: 22052901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inequalities in the Access to Advanced Therapy in Heart Failure.
    Greig D; Olivares G
    Heart Fail Clin; 2015 Oct; 11(4):523-8. PubMed ID: 26462092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cost/benefit relations in heart transplantation].
    Scheld HH; Deng MC; Hammel D; Roeder N; Roetker J
    Z Kardiol; 1994; 83 Suppl 6():139-49. PubMed ID: 7863686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Economic aspects of implementation of the mechanical heart, "HeartMate"].
    Kolbye A; Sander Jensen KM; Aldershvile J; Hansen PB; Kjersem AM; Nielsen KS; Olsen PS; Rasmussen B; Vogelsang G
    Ugeskr Laeger; 2000 Jun; 162(26):3722-5. PubMed ID: 10925632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matters to address prior to introducing new life support technology in Japan: three serious ethical concerns related to the use of left ventricular assist devices as destination therapy and suggested policies to deal with them.
    Asai A; Masaki S; Okita T; Enzo A; Kadooka Y
    BMC Med Ethics; 2018 Feb; 19(1):12. PubMed ID: 29482542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. State-of-the-art implantable cardiac assist device therapy for heart failure: bridge to transplant and destination therapy.
    Park SJ; Kushwaha SS; McGregor CG
    Clin Pharmacol Ther; 2012 Jan; 91(1):94-100. PubMed ID: 22113236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.